Carreno-Tarragona G, Alvarez-Larran A, Harrison C, Martinez-Avila JC, Hernandez-Boluda JC, Ferrer-Marin F, Radia DH, Mora E, Francis S, Gonzalez-Martinez T, Goddard K, Perez-Encinas M, Narayanan S, Raya JM, Singh V, Gutierrez X, Toth P, Amat-Martinez P, Mcilwaine L, Alobaidi M, Mayani K, McGregor A, Stuckey R, Psaila B, Segura A, Alvares C, Davidson K, Osorio S, Cutting R, Sweeney CP, Rufian L, Moreno L, Cuenca I, Smith J, Morales ML, Gil-Manso R, Koutsavlis I, Wang L, Mead AJ, Rozman M, Martinez-Lopez J, Ayala R, Cross NCP. CNL and aCML should be considered as a single entity based on molecular profiles and outcomes. Blood Adv. 2023 May 9;7(9):1672-1681. doi: 10.1182/bloodadvances.2022008204. PubMed PMID: 36375042; PubMed Central PMCID: PMC10182308.
AÑO: 2023; IF: 7.4